RPL7L1P1

Across TCGA pan-cancer cohorts, RPL7L1P1 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPL7L1P1 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPL7L1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7L1P1 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

OV, KIRP, and STAD are the cancer types where RPL7L1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	IV	0.224	0.488	.011	78	view →
KIRP	OS	Tertile	All	0.691	0.913	<.001	42	view →
STAD	OS	Tertile	IV	0.130	0.522	<.001	36	view →
ESCA	DFS	Median	IV	0.634	0.205	.006	30	view →
ACC	DFS	Tertile	All	0.057	0.623	.001	27	view →
SKCM	OS	Tertile	III,IV	0.393	0.819	<.001	24	view →
DLBC	DFS	Tertile	All	0.416	0.829	.026	18	view →
PAAD	OS	Tertile	All	0.318	0.597	.032	18	view →
LUAD	DFS	Tertile	IV	0.489	0.925	.005	18	view →
BLCA	DFS	Tertile	IV	0.118	0.477	.010	9	view →
SARC	OS	Tertile	All	0.158	0.597	.024	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPL7L1P1–OV (DFS)

Open the OV breakdown →